candesartan has been researched along with Nephrotic Syndrome in 10 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We used enalapril, an angiotensin-converting enzyme inhibitor (ACEI) and candesartan, an angiotensin II receptor blocker (ARB), for the control of proteinuria in a case of immunosuppressive treatment (IST)-resistant nephrotic syndrome." | 7.73 | Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation. ( Hosoi, G; Ikemiya, M; Ishii, T; Noma, H; Osugi, Y; Sako, M; Yamada, H, 2006) |
| "Treatment with candesartan, an angiotensin-II-receptor blocker (ARB), controlled both hypertension and proteinuria satisfactorily without worsening of his renal function." | 5.32 | A case of nephrotic syndrome associated with renovascular hypertension successfully treated with candesartan. ( Chinda, J; Hasebe, N; Hirayama, T; Imamoto, C; Kikuchi, K; Okada, M; Takahashi, F; Takeuchi, T, 2003) |
| " We subsequently used full dose ramipril, candesartan and aliskiren under a close monitoring of kidney function and electrolytes and examined the effect on proteinuria, clinical course and tolerability over 12 months." | 3.75 | Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation. ( Amann, K; Frank, H; Freiberger, V; Heemann, U, 2009) |
| " We used enalapril, an angiotensin-converting enzyme inhibitor (ACEI) and candesartan, an angiotensin II receptor blocker (ARB), for the control of proteinuria in a case of immunosuppressive treatment (IST)-resistant nephrotic syndrome." | 3.73 | Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation. ( Hosoi, G; Ikemiya, M; Ishii, T; Noma, H; Osugi, Y; Sako, M; Yamada, H, 2006) |
| "Treatment with candesartan, an angiotensin-II-receptor blocker (ARB), controlled both hypertension and proteinuria satisfactorily without worsening of his renal function." | 1.32 | A case of nephrotic syndrome associated with renovascular hypertension successfully treated with candesartan. ( Chinda, J; Hasebe, N; Hirayama, T; Imamoto, C; Kikuchi, K; Okada, M; Takahashi, F; Takeuchi, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Seigneux, S | 1 |
| Courbebaisse, M | 1 |
| Rutkowski, JM | 1 |
| Wilhelm-Bals, A | 1 |
| Metzger, M | 1 |
| Khodo, SN | 1 |
| Hasler, U | 1 |
| Chehade, H | 1 |
| Dizin, E | 1 |
| Daryadel, A | 1 |
| Stengel, B | 1 |
| Girardin, E | 1 |
| Prié, D | 1 |
| Wagner, CA | 1 |
| Scherer, PE | 1 |
| Martin, PY | 1 |
| Houillier, P | 1 |
| Feraille, E | 1 |
| Kuwabara, T | 1 |
| Mori, K | 1 |
| Mukoyama, M | 1 |
| Kasahara, M | 1 |
| Yokoi, H | 1 |
| Saito, Y | 1 |
| Yoshioka, T | 1 |
| Ogawa, Y | 1 |
| Imamaki, H | 1 |
| Kusakabe, T | 1 |
| Ebihara, K | 1 |
| Omata, M | 1 |
| Satoh, N | 1 |
| Sugawara, A | 1 |
| Barasch, J | 1 |
| Nakao, K | 1 |
| Freiberger, V | 1 |
| Amann, K | 1 |
| Heemann, U | 2 |
| Frank, H | 1 |
| Tullus, K | 1 |
| Takahashi, F | 2 |
| Hasebe, N | 1 |
| Chinda, J | 1 |
| Okada, M | 1 |
| Takeuchi, T | 1 |
| Hirayama, T | 2 |
| Imamoto, C | 1 |
| Kikuchi, K | 2 |
| Morton, A | 1 |
| Muir, J | 1 |
| Lim, D | 1 |
| Chang, A | 1 |
| Logar, CM | 1 |
| Finn, LS | 1 |
| Alpers, CE | 1 |
| Seliger, SL | 1 |
| Osugi, Y | 1 |
| Yamada, H | 1 |
| Hosoi, G | 1 |
| Noma, H | 1 |
| Ikemiya, M | 1 |
| Ishii, T | 1 |
| Sako, M | 1 |
| Lutz, J | 1 |
| Risch, K | 1 |
| Liu, S | 1 |
| Antus, B | 1 |
| Schmaderer, C | 1 |
| Roos, M | 1 |
| Ouyang, N | 1 |
| Lehmann, M | 1 |
1 review available for candesartan and Nephrotic Syndrome
| Article | Year |
|---|---|
[Secondary nephrotic syndrome due to cardiovascular disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Diagnosis, Differential | 2004 |
9 other studies available for candesartan and Nephrotic Syndrome
| Article | Year |
|---|---|
Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling.
Topics: Adult; Albuminuria; Analysis of Variance; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Wes | 2015 |
Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Albumins; Angiotensin II Type 1 Receptor Blockers; Animal | 2009 |
Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.
Topics: Adult; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; An | 2009 |
Safety concerns of angiotensin II receptor blockers in preschool children.
Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Anti | 2011 |
A case of nephrotic syndrome associated with renovascular hypertension successfully treated with candesartan.
Topics: Aged; Angiography, Digital Subtraction; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; | 2003 |
Rash and acute nephritic syndrome due to candesartan.
Topics: Acute Disease; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazole | 2004 |
A rare cause of necrotizing and crescentic glomerulonephritis in a young adult male.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Autoa | 2005 |
Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphe | 2006 |
Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathy.
Topics: Angiotensin Receptor Antagonists; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Chronic Di | 2006 |